These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 30115466)
1. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis. Li Y; Xu T; Qian W; Lu X; Hu C Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466 [TBL] [Abstract][Full Text] [Related]
2. Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose-volume-outcome analysis. Ni MS; Kong FF; Pan GS; Du CR; Zhai RP; Hu CS; Ying HM Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1425-1434. PubMed ID: 37995006 [TBL] [Abstract][Full Text] [Related]
3. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis. Sun Y; Zhou GQ; Qi ZY; Zhang L; Huang SM; Liu LZ; Li L; Lin AH; Ma J BMC Cancer; 2013 Aug; 13():397. PubMed ID: 23978128 [TBL] [Abstract][Full Text] [Related]
4. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients. Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Wu M; Ou D; He X; Hu C Oral Oncol; 2017 Oct; 73():118-123. PubMed ID: 28939063 [TBL] [Abstract][Full Text] [Related]
6. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT. Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030 [TBL] [Abstract][Full Text] [Related]
7. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis. Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884 [TBL] [Abstract][Full Text] [Related]
8. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma. Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397 [TBL] [Abstract][Full Text] [Related]
9. Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. He X; Ou D; Ying H; Zhu G; Hu C; Liu T Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1027-33. PubMed ID: 21706324 [TBL] [Abstract][Full Text] [Related]
10. Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies. Xu Y; Liu Y; Wang Z; Wang J; Zhang J; Chen X; Wu R; Liu Q; Qu Y; Wang K; Huang X; Luo J; Gao L; Xu G; Zhang Y; Yi J Radiat Oncol; 2022 Jan; 17(1):13. PubMed ID: 35062991 [TBL] [Abstract][Full Text] [Related]
11. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship. Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300 [TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma. Wu L; Chung YL Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091 [TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost. Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757 [TBL] [Abstract][Full Text] [Related]
14. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma. Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310 [TBL] [Abstract][Full Text] [Related]
15. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study. Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of follow-up results of chrono-chemotherapy or conventional chemotherapy combined with intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma]. Liu KQ; Jin F; Jiang H; Wu WL; Li YY; Long JH; Luo XL; Gong XY; Chen XX; Liu LN; Gan JY; Zhou JJ Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):133-138. PubMed ID: 32135648 [No Abstract] [Full Text] [Related]
17. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study. Wei Z; Zhang Z; Luo J; Li N; Peng X J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162 [TBL] [Abstract][Full Text] [Related]
18. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy. Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study. Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809 [TBL] [Abstract][Full Text] [Related]
20. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients. Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]